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pertension, serum cholesterol, and diabetes mellitus decreases the risk of Parkin-
son’s disease (PD). We therefore examined the epidemiologic association of PD
with hypertension, serum total cholesterol, and diabetes mellitus by conducting a
detailed meta-analysis of all studies published regarding this subject.METHODS:A
systematic comprehensive literature search was performed using PubMed,
EMBASE, and CINAHL (until March 2012) for observational cohort and case-control
studies using relevant keywords. Pooled relative risk (RR) was calculated using
random effects model. Pre specified subgroup analysis was performed to assess the
source of heterogeneity, according to study design, number of covariates adjusted
and adjusted for BMI and cardiovascular diseases. Subgroup and sensitivity anal-
ysis were also done. Heterogeneity and publication bias were also assessed.
RESULTS: 24 studies were included in the analysis. The pooled risk ratio of PD due
to hypertension (n8) was 0.78 (95% CI, 0.67-0.92, I271.85%), due to high serum
cholesterol (n7) was 0.95 (95% CI, 0.77-1.17, I2 75.86%), and due to diabetes
(n14) was 0.94 (95% CI, 0.76-1.16, I2 89.62%). Subgroup analysis showed a signif-
icant difference in effect estimate pooled by cohort and case-control studies (Pin-
teraction0.001). Pooled analysis of cohort studies for diabetes showed a pooled
risk ratio of 1.34 (95%CI, 1.12-1.60, I276.77%). We found no significant difference in
any subgroup analysis. CONCLUSIONS: We found evidence of significant inverse
associations of hypertension, hypercholesterolemia, and diabetes mellitus with
the risk of PD. Further well-designed investigations of the association of vascular
risk factors with the risk of PD are needed, particularly large-scale prospective
studies.
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OBJECTIVES: Technological developments allow remote monitoring of patients
and improve diabetes care. A mobile phone telemonitoring system (TM) might
improve the ability of DM patients to engage in treatment. The objective is to
estimate the annual costs that implementing a TM for glycaemic control in DM
patients might represent to the National Health System and to society in Spain.
METHODS: First, a systematic review of the literature was conducted to determine
cost drivers in DM TM. Electronic databases were searched to identify national and
international clinical and economic articles, published between January, 2001 and
December, 2011, reporting on the clinical benefits, health resources used and costs
associated to DM TM. Second, based on the data gathered, and adapted for Spain,
and on the assumption that TM favors treatment compliance, a mathematical
model was applied to determine the variation in costs associated to macro and
micro DM complications risk reduction derived from hypothetically reaching 100%
DM treatment compliance in groups of patients: compliant, noncompliant and
complications are undiagnosed. RESULTS: A total of 3.539 articles were identified;
48 were reviewed. TM decreases emergency visits (83%), disease related hospital
admissions (75%), length of hospital admission (51%), visits to the outpatient clinic
(40%) and to the specialist (19%). Reduction of indirect costs reaches 120.82 €per DM
patient/year due to less travel expenses (-6.30 €/visits) and productivity gain (-54
€/visits). Assuming that 100% of uncompliant DM patients become compliant (n 
1,550,634 patients) costs associated to macro- and micro-vascular complications
decreases by 5,500 € (€, 2011) million per year. Higher cost reductions are obtained
in the most prevalent vascular complications. CONCLUSIONS: These preliminary
results show that TM in DM patients reduces direct and indirect costs. Significant
costs reduction can be reached if DM treatment compliance is improved with TM in
Spain.
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OBJECTIVES: To carry out a clinical-economic analysis of MoliCare® Premium ex-
tra soft diapers application efficiency for contact dermatitis* and pressure ulcers
prophylaxis with immobile urinary-incontinent patients.METHODS: Estimation of
typical management practice with immobile urinary-incontinent patients’ having
developed contact dermatitis* or pressure ulcers was performed by means of ex-
perts’ questioning. Only direct medical costs were taken into account in the re-
search. A comparative clinical-economic analysis was performed using Markov’s
model. A sensitivity analysis was performed taking into account retail and whole-
sale prices for absorbing means and skin care agents. RESULTS: Twenty weeks’
total costs calculated with Markov’s model use for contact dermatitis* and 1-4
degree pressure ulcers prophylaxis and treatment with one immobile urinary-
incontinent patient with absorbent means and skin care agents’ application were
5508 € in retail prices and 5276 € in wholesale prices; without their application the
costs were 7 446 €. Overall this Analysis shows that medical-prophylactic institu-
tions’ costs for contact dermatitis* and pressure ulcers’ prophylaxis and treatment
with one immobile urinary-incontinent patient without absorbing means and skin
care agents applying are considerably higher (by 41%) than when they are applied.
At the same time indirect costs including linen disinfection, washing, drying and
ironing were not taken into account and such costs can increase a costs’ total
figure. CONCLUSIONS:Absorbent means and skin care agents’ application for con-
tact dermatitis and pressure ulcers prophylaxis and treatment with immobile uri-
nary-incontinent patients is a dominant technique and cost efficacy of using ab-
sorbent means and skin care agents was demonstrated. The Branch standard
“Patients’ management protocol. Pressure ulcers” (2002) needs actualization taking
into account the data obtained in the present clinical-economic research.
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OBJECTIVES: To quantify the financial effects of the introduction of a recommen-
dation for rotavirus vaccination in Saxony, Germany, in 2008 using a retrospective
data analysis. Special emphasis is given to the herd effect.METHODS:We analyzed
the costs of rotavirus infection between 2007 and 2010 based on 360.000 observa-
tions from the AOK Plus of children under 5 years for Saxony. To investigate the
cost impact of the regional recommendation, we compared the associated costs of
the expected annual RVGE cases derived from 2005 when rotavirus vaccination was
not yet available, with the actual annual number of RVGE cases, vaccinations and
associated costs per age cohort. A decrease in RVGE cases in not vaccinated cohorts
was attributed to herd effect. We make distinction between in- and outpatient
cases, societal and SHI perspective as well as different age groups. RESULTS: Given
that the vaccination rate has increased from 5% to 61% in the observed period, we
obtained following estimates: the mean total cost reduction per year attributable to
introducing a recommendation for rotavirus vaccination is 4.5 million € (2.4 million
€) from the societal (SHI) perspective. The mean cost savings of vaccination per
avoided case rise from 572 € (291 €) in 2007 to 718 € (375 €) in 2010. The overall share
of outpatient costs is about 72% (60%). About 45% of the total savings is attributable
to herd effect. The herd effect per avoided case decreases over time while immu-
nity increases. CONCLUSIONS: A recommendation for rotavirus vaccination in
Saxony turns out to be cost saving from the SHI as well as the societal perspective.
This is mainly attributed to the herd effect being present when having high vacci-
nation rates.
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OBJECTIVES: To determine the relationship of polypharmacy on blood pressure
(BP) control, compliance, persistence, the cost and incidence of cardiovascular
events (CVD) in patients with moderate/severe hypertension. METHODS: An ob-
servational multicenter retrospective study. We evaluated patients 30 years who
started a third antihypertensive treatment during 2004-2006. Depending on the
number of chronic medications, we established 3 groups: regular consumption of
3-6 drugs, between 7-10 and 11. Top measures: sociodemographic, comorbidity,
BP, compliance and persistence. For each group we determined the incidence of
new CVD and total costs. Patients were followed for 4 years. RESULTS: We evalu-
ated 1,906 patients, 765 between 3-6 drugs, 624 between 7-10 and 517 in _ 11 (P 
0.001). Overage age: 69.4 years and 55.5% women. The group of 3-6 drugs showed
better BP control (51.8 vs. 47.0 and 41.1%, P  0.001), compliance (71.4 vs. 69.9 and
67.1%, P 0.017), persistence (50.1 vs. 45.5 and 46.2%, P 0.044) and lower incidence
of CVD (12.2 vs. 19.7 and 30.2%, P 0.001), respectively. The average/unit total cost
was 3,369.1 vs. 4,362.1 and s 4,902.3 (P 0.001). The presence of CVD was associated
with therapy non-compliance (odds ratio [OR] 1.9, 95% confidence interval [95% CI]
1.1 to 3.6) and lower BP control (OR 1.4 [95% CI 1.1-2.0], P  0.05). The use of anti-
hypertensive fixed dose has greater compliance (72.8 vs. 68.2%), persistence (64.4
vs. 39.3%) and degree of BP control (52.6 vs. 43, 8%), P  0.001. CONCLUSIONS:
Polypharmacy is associated with lower compliance and persistence to antihyper-
tensive treatment, cardiovascular disease and increased health care costs.
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OBJECTIVES:We estimated the impact of influenza A(H1N1)2009 infection in terms
of patient’s health care services utilization, work absenteeism and costs, both dur-
ing the pandemic (2009-10) and postpandemic-seasonal (2010-11) waves in Spain.
METHODS: Longitudinal, multi-centre study of in- and outpatients with RT-PCR
confirmed diagnosis of influenza at pandemic(PAND) and postpandemic-season-
al(POST) waves. Health care and social resources utilization were the main vari-
ables, together with clinical and sociodemographic characteristics. Evaluations
were conducted at hospital-admission or ambulatory index-visit, and after recov-
ery (median100 days). Unitary costs and Monte Carlo simulation were applied to
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